Market Watch

Savara to Join Russell Microcap Index

Savara to Join Russell Microcap Index

June 20, 2017 at 3:05 pm 0 comments

Savara Inc. said early Tuesday it will join the Russell Microcap Index at the conclusion of the Russell indexes annual reconstitution, effective at U.S. market open on June 26. Membership in the Russell Microcap Index, which remains in place for one year, provides automatic inclusion in the appropriate growth and value style indexes, the company said in a press release.Read More

Sonoco Products Restates Price Increase

Sonoco Products Restates Price Increase

June 13, 2017 at 10:48 am 0 comments

Sonoco Products Company restated and is implementing a previously announced price increase for all grades of uncoated recycled paperboard (URB) products in the US and Canada, effective July 10. The company said that the low yield on the previously announced April URB price increase, along with the impact of rising raw material and other costs, makes it necessary to goRead More

Pfizer, Astellas Amend Research Protocol

Pfizer, Astellas Amend Research Protocol

June 9, 2017 at 11:54 am 0 comments

Pfizer and partner Astellas Pharma said pre-market Friday that they have amended the protocol for the registrational PROSPER trial, a double-blind, placebo-controlled study evaluating the efficacy and safety of Xtandi in patients with non-metastatic castration-resistant prostate cancer. The main purpose of the amendment is to revise the plan for the analyses of the primary and several secondary endpoints, which allowsRead More

Cerus Shares Gain

Cerus Shares Gain

June 7, 2017 at 12:03 pm 0 comments

Cerus shares were 10% higher Wednesday after the biomedical products company said that the expected shortage of platelet additive solution from Fresenius Kabi, announced in May, could be less disruptive to the blood center production of the company’s Intercept platelets than initially anticipated. Ceres said this follows a decision by the U.S. Food and Drug Administration to review a recentRead More

Five Prime Therapeutics Unveils Phase 1 Data

Five Prime Therapeutics Unveils Phase 1 Data

June 5, 2017 at 12:57 pm 0 comments

Five Prime Therapeutics said on Saturday that it presented data from a phase 1 trial of FPA 144 for the treatment of gastric cancer, as well as for cabralizumab in patients with pigmented villonodular synovitis (PVNS) at the American Society of Clinical Oncology Annual Meeting in Chicago. Part 2 of the ongoing phase 1 trial of FPA 144 is evaluatingRead More

USD-CAD Pulls Back from One-Week High

USD-CAD Pulls Back from One-Week High

May 30, 2017 at 11:37 am 0 comments

USD-CAD has pulled back from the one-week high of 1.3506 posted earlier in the session, currently trading at 1.3473. The pairing had been supported by the reported widening in Canada’s Q1 current account deficit, and West Texas Intermediate crude prices down near $49.00/bbl, though sellers returned above the figure, and the 50-day moving average at 1.3495. Sterling has managed toRead More

Howard Hughes Shares Gain

Howard Hughes Shares Gain

May 8, 2017 at 4:18 pm 0 comments

Howard Hughes shares jumped more than 3% intraday, touching their highest level since August 2015, after billionaire hedge fund manager Bill Ackman made a bullish pitch for the company at the Sohn Investment Conference in New York, according to a report from CNBC. “I think this is one of the most attractive times in the history of the company toRead More